UK Dietary Practices for Tyrosinaemias: Time for Change
Abstract
:1. Introduction
2. Methods
- The general dietary principles to be used for HTI, HTII and HTIII.
- The dietary exchange system to be adopted: either a 1 g protein exchange system or a combination of tyrosine/phenylalanine (mg/100 g protein). This distinguished between foods that contain 5% phenylalanine and 3–4% tyrosine for each gram of protein from milk and cereals and foods that contain 3–4% phenylalanine and 2–3% tyrosine for each gram of protein from fruit and vegetables [18].
- Clear definitions for measuring/calculating protein or phenylalanine/tyrosine from manufactured foods and when these can be given as part of the dietary exchange system or given without measurement.
- (1)
- ‘McCance and Widdowson’s The Composition of Foods’ 1980, First supplementary amino acid mg/100 g foods [18];
- (2)
- National society for phenylketonuria (NSPKU) database [19] and (personal communication);
- (3)
- Amino acid composition of food products used in the treatment of patients with disorders of amino acid and protein metabolism [20];
- (4)
- United States of America Department of Agriculture (USDA: United States Department of Agriculture, Agriculture Research Service www.usda.gov (accessed on 3 March 2021)) [21];
- (5)
- Mevalia website database (www.Mevalia.com (accessed on 3 March 2020)) based on Frida.fooddata.dk version 4 National Food Institute, Technical University of Denmark [22].
- The number and types of HT patients being managed in each treatment centre;
- The dietary management practices of each treatment centre, including the type of exchange system used;
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Holme, E.; Lindstedt, S. Nontransplant treatment of tyrosinemia. Clin. Liver Dis. 2000, 4, 805–814. [Google Scholar] [CrossRef] [PubMed]
- Van Spronsen, F.J.; Thomasse, Y.; Smit, G.P.; Leonard, J.V.; Clayton, P.T.; Fidler, V.; Berger, R.; Heymans, H.S. Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment. Hepatology 1994, 20, 1187–1191. [Google Scholar] [CrossRef] [PubMed]
- Iskeleli, G.; Bilgec, M.D.; Arici, C.; Atalay, E.; Oğreden, T.; Aydin, A. Richner-Hanhart syndrome (tyrosinemia type II): A case report of delayed diagnosis with pseudodendritic corneal lesion. Turk. J. Pediatr. 2011, 53, 692–694. [Google Scholar] [PubMed]
- Miranda, B.A.; Rocha, A.C.H.; Arantes, R.R.; Kanufre, V.D.C.; Silva, S.C.; Vasconcelos-Santos, D.V. Bilateral recurrent pseudodendritic keratopathy as the initial manifestation of tyrosinemia type II. Ophthalmic Genet. 2022, 43, 282–284. [Google Scholar] [CrossRef]
- Cerone, R.; Holme, E.; Schiaffino, M.C.; Caruso, U.; Maritano, L.; Romano, C. Tyrosinemia type III: Diagnosis and ten-year follow-up. Acta Paediatr. 1997, 86, 1013–1015. [Google Scholar] [CrossRef]
- Ellaway, C.J.; Holme, E.; Standing, S.; Preece, M.A.; Green, A.; Ploechl, E.; Ugarte, M.; Trefz, F.K.; Leonard, J.V. Outcome of tyrosinaemia type III. J. Inherit Metab. Dis. 2001, 24, 824–832. [Google Scholar] [CrossRef]
- Dam, E.V.; Daly, A.; Venema-Liefaard, G.; Rijn, M.V.; Derks, T.G.; McKiernan, P.J.; Rebecca Heiner-Fokkema, M.; MacDonald, A.; Spronsen, F.J.V. What Is the Best Blood Sampling Time for Metabolic Control of Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients? JIMD Rep. 2017, 36, 49–57. [Google Scholar]
- Bärhold, F.; Meyer, U.; Neugebauer, A.-K.; Thimm, E.M.; Lier, D.; Rosenbaum-Fabian, S.; Och, U.; Fekete, A.; Möslinger, D.; Rohde, C.; et al. Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome. Nutrients 2020, 13, 134. [Google Scholar] [CrossRef]
- Chinsky, J.M.; Singh, R.; Ficicioglu, C.; Van Karnebeek, C.D.; Grompe, M.; Mitchell, G.; Waisbren, S.E.; Gucsavas-Calikoglu, M.; Wasserstein, M.P.; Coakley, K.; et al. Diagnosis and treatment of tyrosinemia type I: A US and Canadian consensus group review and recommendations. Genet Med. 2017, 19, 1380. [Google Scholar] [CrossRef] [Green Version]
- Barroso, F.; Correia, J.; Bandeira, A.; Carmona, C.; Vilarinho, L.; Almeida, M.; Rocha, J.C.; Martins, E. Tyrosinemia Type Iii: A Case Report of Siblings and Literature Review. Rev. Paul. Pediatr. 2020, 38, e2018158. [Google Scholar] [CrossRef]
- Szymanska, E.; Sredzinska, M.; Ciara, E.; Piekutowska-Abramczuk, D.; Ploski, R.; Rokicki, D.; Tylki-Szymanska, A. Tyrosinemia type III in an asymptomatic girl. Mol. Genet Metab. Rep. 2015, 5, 48–50. [Google Scholar] [CrossRef] [PubMed]
- Couce, M.L.; Aldámiz-Echevarría, L.; Baldellou, A.; Blasco, J.; Bueno, M.A.; Dalmau, J.; De La Vega, A.; Del Toro, M.; Díaz, C.; Lama, R.; et al. Recommendations and management of type I hereditary or hepatorenal tyrosinemia. An. Pediatr. 2010, 73, 279.e1–279.e4. [Google Scholar] [CrossRef] [PubMed]
- De Laet, C.; Dionisi-Vici, C.; Leonard, J.V.; McKiernan, P.; Mitchell, G.; Monti, L.; De Baulny, H.O.; Pintos-Morell, G.; Spiekerkötter, U. Recommendations for the management of tyrosinaemia type 1. Orphanet J. Rare Dis. 2013, 8, 8. [Google Scholar] [CrossRef] [Green Version]
- Clinical Paediatric Dietetics, 5th ed.; Shaw, V. (Ed.) CPI Group (UK) Ltd.: Croydon, UK, 2020. [Google Scholar]
- Evans, S.; Ford, S.; Adam, S.; Adams, S.; Ash, J.; Ashmore, C.; Caine, G.; Carruthers, R.; Cawtherley, S.; Chahal, S.; et al. Development of national consensus statements on food labelling interpretation and protein allocation in a low phenylalanine diet for PKU. Orphanet J. Rare Dis. 2019, 14, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Evans, S.; Adam, S.; Adams, S.; Allen, H.; Ashmore, C.; Bailey, S.; Banks, J.; Churchill, H.; Cochrane, B.; Cook, J.; et al. Uniformity of Food Protein Interpretation Amongst Dietitians for Patients with Phenylketonuria (PKU): 2020 UK National Consensus Statements. Nutrients 2020, 12, 2205. [Google Scholar] [CrossRef] [PubMed]
- Niederberger, M.; Spranger, J. Delphi Technique in Health Sciences: A Map. Front. Public Health 2020, 8, 457. [Google Scholar] [CrossRef]
- McCance, R.A.; Widdowson Elsie, M.; Paul, A.A.; Southgate, D.A.T.; Russell, J. McCance and Widdowson’s The Composition of Foods. In 1st Supplementary Amino Acids, Mg Per 100G Food, Fatty Acids G per 100G Food; HMSO: London, UK, 1980. [Google Scholar]
- Weetch, E.; Macdonald, A. The determination of phenylalanine content of foods suitable for phenylketonuria. J. Hum. Nutr. Diet 2006, 19, 229–236. [Google Scholar] [CrossRef]
- Bremer, H.J.; Anninos, A.; Schulz, B. Amino acid composition of food products used in the treatment of patients with disorders of the amino acid and protein metabolism. Eur. J. Pediatr. 1996, 155 (Suppl. S1), S108–S114. [Google Scholar] [CrossRef]
- USDA. United States Department of Agriculture, Agriculture Research Service. Available online: www.usda.gov (accessed on 3 March 2021).
- Denmark Techinical University. National Food Institute. Available online: www.frida.fooddata.dk (accessed on 3 March 2021).
- MacDonald, A.; Van Wegberg, A.M.J.; Ahring, K.; Beblo, S.; Bélanger-Quintana, A.; Burlina, A.; Campistol, J.; Coşkun, T.; Feillet, F.; Giżewska, M.; et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J. Rare Dis. 2020, 15, 171. [Google Scholar] [CrossRef]
- Paul, A.A.; Southgate, D.A.; Buss, D.H. McCance and Widdowson’s ‘The composition of foods’: Supplementary information and review of new compositional data. Hum. Nutr. Appl. Nutr. 1986, 40, 287–299. [Google Scholar]
- van Vliet, K.; Rodenburg, I.L.; van Ginkel, W.G.; Lubout, C.M.; Wolffenbuttel, B.H.; van der Klauw, M.M.; Heiner-Fokkema, M.R.; van Spronsen, F.J. Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients. Nutrients 2019, 11, 2011. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Äärelä, L.; Hiltunen, P.; Soini, T.; Vuorela, N.; Huhtala, H.; Nevalainen, P.I.; Heikinheimo, M.; Kivelä, L.; Kurppa, K. Type 1 tyrosinemia in Finland: A nationwide study. Orphanet J. Rare Dis. 2020, 15, 281. [Google Scholar] [CrossRef] [PubMed]
- Masurel-Paulet, A.; Poggi-Bach, J.; Rolland, M.-O.; Bernard, O.; Guffon, N.; Dobbelaere, D.; Sarles, J.; De Baulny, H.O.; Touati, G. NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients. J. Inherit Metab. Dis. 2008, 31, 81–87. [Google Scholar] [CrossRef] [PubMed]
- Mayorandan, S.; Meyer, U.; Gokcay, G.; Segarra, N.G.; De Baulny, H.O.; Van Spronsen, F.; Zeman, J.; De Laet, C.; Spiekerkoetter, U.; Thimm, E.; et al. Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. Orphanet. J. Rare Dis. 2014, 9, 107. [Google Scholar] [CrossRef] [Green Version]
- van Ginkel, W.G.; van Reemst, H.E.; Kienstra, N.S.; Daly, A.; Rodenburg, I.L.; MacDonald, A.; Burgerhof, J.G.; de Blaauw, P.; van de Krogt, J.; Santra, S.; et al. The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients. Nutrients 2019, 11, 2816. [Google Scholar] [CrossRef] [Green Version]
- Spronsen, F.J.V.; Rijn, M.V.; Meyer, U.; Das, A.M. Dietary Considerations in Tyrosinemia Type I. Adv. Exp. Med. Biol. 2017, 959, 197–204. [Google Scholar]
- Yilmaz, O.; Daly, A.; Pinto, A.; Ashmore, C.; Evans, S.; Gupte, G.; Santra, S.; Preece, M.A.; McKiernan, P.; Kitchen, S.; et al. Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1. Nutrients 2020, 12, 1148. [Google Scholar] [CrossRef] [Green Version]
- MacDonald, A. Diet and phenylketonuria: A time for change. J. Hum. Nutr. Diet. 1994, 7, 105–114. [Google Scholar] [CrossRef]
- Van Wegberg, A.M.J.; Macdonald, A.; Ahring, K.; BéLanger-Quintana, A.; Blau, N.; Bosch, A.M.; Burlina, A.; Campistol, J.; Feillet, F.; Giżewska, M.; et al. The complete European guidelines on phenylketonuria: Diagnosis and treatment. Orphanet J. Rare Dis. 2017, 12, 162. [Google Scholar] [CrossRef] [Green Version]
- Moughan, P.J. Amino acid availability: Aspects of chemical analysis and bioassay methodology. Nutr. Res. Rev. 2003, 16, 127–141. [Google Scholar] [CrossRef] [Green Version]
- Otter, D.E. Standardised methods for amino acid analysis of food. Br. J. Nutr. 2012, 108 (Suppl. S2), S230–S237. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mandrioli, R.; Mercolini, L.; Raggi, M.A. Recent trends in the analysis of amino acids in fruits and derived foodstuffs. Anal. Bioanal. Chem. 2013, 405, 7941–7956. [Google Scholar] [CrossRef] [PubMed]
Number of Paediatric Centres Caring for HT Patients Aged ≤16 Years (Range for Number of Patients/Centre) | Number of Patients Aged ≤16 Years n | Number of Adult Centres Caring for HT Patients Aged ≥17 Years (Range for Number of Patients/Centre) | Number of Patients Aged ≥17 Years n | Total Number of Patients n |
---|---|---|---|---|
HTI n = 8/8 (1–12) | 44 | HTI n = 4/6 (3–12) | 31 | 75 |
HTII n = 5/8 (1) | 5 | HTII n = 4/6 (1–2) | 5 | 10 |
HTIII n = 3/8 (1–4) | 7 | HTIII n = 2/6 (2–3) | 7 | 14 |
Adult and Paediatric Responses | HTI (n = 12 Centres) | HTII (n = 9 Centres) | HTII (n = 6 Centres) |
---|---|---|---|
Manufactured Foods | |||
Use of 1 g protein exchanges to calculate exchanges from manufactured foods | 12/12 (100%) | 7/9 (78%) | 5/6 (83%) |
Use of phenylalanine/tyrosine exchanges | 0/12 (0%) | 0/9 (0%) | 0/6 (0%) |
Fruit and vegetables | |||
The upper protein cut off point (g/100 g) that is used to define when vegetables are calculated/measured within the exchange system * | |||
≤1.0 g | 7/8 (88%) | 3/5 (60%) | 2/3 (67%) |
≤1.5 g | 1/8 (13%) | 1/5(20%) | 1/3 (33%) |
≤2.0 g | 0/8 (0%) | 1/5 (20%) | 0/3 (0%) |
The upper protein cut off point (g/100 g) that is used to define when fruits are calculated/measured within the exchange system * | |||
≤1.0 g | 8/9 (89%) | 4/6 (67%) | 2/3 (67%) |
≤1.5 g | 1/9 (11%) | 1/6 (17%) | 1/3 (33%) |
≤2.0 g | 0/9 (0%) | 1/6 (17%) | 0/3 (0%) |
Voting Agreement by Treatment Centres | Number or Voting Rounds | |||
---|---|---|---|---|
HTI Number of Centres n = 12 | HTII Number of Centres n = 9 | HTIII Number of Centres n = 6 | ||
Statement 1: the following protein cut-off point is used to define an exchange-free food i.e., if the protein content exceeds this amount, it should be calculated as an exchange food (this is the same as the UK PKU dietary guidelines) [16] * | ||||
An exchange-free food defined as a food not calculated/measured, and when the protein content is ≤0.5 g/100 g (except fruit, vegetables and some manufactured foods e.g., sweets, gravies and desserts) | 11/12 (92%) | 6/6 (100%) | 4/4 (100%) | Round 1 |
Statement 2–9: the following manufactured foods should be calculated/measured as part of the protein exchange system if the protein content exceeds the following upper protein amounts given below (this is the same as the UK PKU dietary guidelines) [16] * | ||||
Tabletop sauces (e.g., ketchup, brown, chilli, BBQ sauces) containing exchange ingredients with a protein content >1 g/100 g | 10/12 (83%) | 4/6 (67%) | 2/3 (67%) | Round 1 |
Mayonnaise/salad cream dressings containing exchange ingredients with a protein content >1 g/100 g | 11/12 (92%) | 5/6 (84%) | 2/3 (67%) | Round 1 |
Cook-in liquid sauces containing exchange ingredients with a protein content >1 g/100 g | 12/12 (100%) | 6/6 (100%) | 3/3 (100%) | Round 1 |
Soya sauce with a protein content >1.5 g/100 g | 10/12 (83%) | 4/6 (67%) | 2/3 (67%) | Round 1 |
Special low protein foods containing exchange ingredients with a protein content >0.5 g/100 g | 10/11 (91%) | 6/6 (100%) | 3/3 (100%) | Round 1 |
Plant milks/special low protein milks are exchange-free if protein content is ≤0.1 g/100 mL; and should be calculated/ measured as part of protein exchange system if the protein content is >0.1 g/100 mL | 7/10 (70%) | 3/5 (60%) | 1/2 (50%) | Round 1 |
The protein cut off point for plant milks should be: ≤0.1 g/100 mL = exchange-free; >0.1 g/100 mL is an exchange food. This guidance applies to HTI, HTII, HTIII | 6/11 (55%) | Round 2 | ||
The majority of plant milks should be calculated as a protein exchange in tyrosinemia. However, any plant milk containing a protein content of only 0.1 g/100 mL can be given as exchange-free. This statement applies to HTI, HTII, HTIII | 10/11 (91%) | Final Round 3 | ||
Statement 10: Phenylalanine/tyrosine analysis should be used in the allocation of fruit and vegetables in the dietary treatment of HT’s | ||||
Phenylalanine/tyrosine analysis | 9/11 (82%) | 5/6 (83%) | 3/3 (100%) | Round 2 |
Protein analysis | 2/11 (18%) | 1/6 (17%) | 0/3 (0%) | |
Statement 11: The same dietary system should be used for Tyrosinaemia Type I, II and III | ||||
Agreement | 9/9 (100%) | Round 2 |
Food | Protein /100 g | Phe mg /100 g | Tyr mg /100 g | * Phe g /100 g | * Tyr g /100 g | % Phe/g Protein | % Tyr/g Protein |
---|---|---|---|---|---|---|---|
Protein, phenylalanine and tyrosine content of meat, milk, egg | |||||||
Beef cooked | 29.2 | 1310 | 1120 | 1.3 | 1.1 | 4 | 4 |
Egg boiled | 12.3 | 630 | 490 | 0.6 | 0.5 | 5 | 4 |
Yoghurt | 4.8 | 280 | 240 | 0.3 | 0.2 | 6 | 5 |
Milk | 3.3 | 180 | 150 | 0.2 | 0.2 | 5 | 5 |
Protein, phenylalanine and tyrosine content of cereal-based foods | |||||||
Oats | 12.4 | 660 | 450 | 0.7 | 0.5 | 5 | 4 |
Cornflakes | 8.6 | 430 | 330 | 0.4 | 0.3 | 5 | 4 |
White flour | 9.8 | 520 | 280 | 0.5 | 0.3 | 5 | 3 |
Rice boiled | 2.2 | 110 | 93 | 0.1 | 0.1 | 5 | 4 |
Porridge | 1.4 | 74 | 50 | 0.1 | 0.1 | 5 | 4 |
Protein, phenylalanine and tyrosine content of vegetables | |||||||
Mushroom fried | 2.2 | 120 | 110 | 0.1 | 0.1 | 5 | 5 |
Beetroot | 1.3 | 46 | 46 | 0.05 | 0.05 | 3.5 | 3.5 |
Carrots boiled | 0.6 | 17 | 14 | 0.02 | 0.01 | 3 | 2 |
Tomatoes | 0.9 | 15 | 11 | 0.02 | 0.01 | 1.6 | 1.2 |
Turnips | 0.9 | 14 | 10 | 0.01 | 0.01 | 1.5 | 1.1 |
Fruit/Vegetable | Comment | Decision of the Group |
---|---|---|
Cauliflower | Of 8 different international analyses, 5/8 indicated that cauliflower was low in protein, tyrosine and phenylalanine, and 3/8 suggested it should be considered an exchange vegetable. Further analysis is necessary. | To include as an exchange vegetable until further analysis is available, in line with current recommendations for PKU. |
Mushrooms | Seven of 8 analyses suggested a low tyrosine/phenylalanine content so should be considered an exchange-free vegetable, although the protein content was >2 g/100 g for 7/8 analyses. However, mushrooms have a measurable amount of non-protein nitrogen in the form of urea, purines and pyrimidines. | To include as an exchange-free vegetable. |
Watercress | There was limited protein and tyrosine/phenylalanine analyses (n = 3). The UK analysis suggested that watercress was low in tyrosine/phenylalanine although protein content >2 g/100 g. | To include as an exchange-free vegetable until further analysis is available, in line with current recommendations for PKU. |
Avocado | Although the protein content was ≤2.0 g/100 g, 2/6 international phenylalanine analyses exceeded 75 mg/100 g, but 4/6 were ≤75 mg/100 g. | To include as an exchange-free vegetable until further analysis is available, in line with current recommendations for PKU. |
Prunes | There was limited protein and tyrosine/phenylalanine analysis (n = 1). Although the protein content was >2.0 g/100 g, the tyrosine/phenylalanine content was low. | To include as an exchange-free fruit until further analysis is available. |
|
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Daly, A.; Adam, S.; Allen, H.; Ash, J.; Dale, C.; Dixon, M.; Dunlop, C.; Ellerton, C.; Evans, S.; Firman, S.; et al. UK Dietary Practices for Tyrosinaemias: Time for Change. Nutrients 2022, 14, 5202. https://doi.org/10.3390/nu14245202
Daly A, Adam S, Allen H, Ash J, Dale C, Dixon M, Dunlop C, Ellerton C, Evans S, Firman S, et al. UK Dietary Practices for Tyrosinaemias: Time for Change. Nutrients. 2022; 14(24):5202. https://doi.org/10.3390/nu14245202
Chicago/Turabian StyleDaly, Anne, Sarah Adam, Heather Allen, Jane Ash, Clare Dale, Marjorie Dixon, Carolyn Dunlop, Charlotte Ellerton, Sharon Evans, Sarah Firman, and et al. 2022. "UK Dietary Practices for Tyrosinaemias: Time for Change" Nutrients 14, no. 24: 5202. https://doi.org/10.3390/nu14245202
APA StyleDaly, A., Adam, S., Allen, H., Ash, J., Dale, C., Dixon, M., Dunlop, C., Ellerton, C., Evans, S., Firman, S., Ford, S., Freedman, F., Gribben, J., Howe, S., Khan, F., McDonald, J., McStravick, N., Nguyen, P., Oxley, N., ... MacDonald, A., on behalf of the British Inherited Metabolic Diseases Group (BIMDG) Dietitians Group. (2022). UK Dietary Practices for Tyrosinaemias: Time for Change. Nutrients, 14(24), 5202. https://doi.org/10.3390/nu14245202